Oncogenic mechanisms mediated by DNA methylation

Weinberg, 1996, How cancer arises, Sci. Am., 275, 62, 10.1038/scientificamerican0996-62 Ashby, 1991, Definitive relationships among chemical structure carcinogenicily and mutagenicity for 301 chemicals tested by the U.S. NTP, Mutat. Res., 257, 229, 10.1016/0165-1110(91)90003-E Rubin, 1992, Cancer development: the rise of epigenetics, Eur. J. Cancer, 28, 1, 10.1016/0959-8049(92)90369-D Cuthill, 1994, Cellular epigenetics and the origin of cancer, BioEssays, 16, 393, 10.1002/bies.950160606 Prehn, 1994, Cancers beget mutations versus mutations beget cancers, Cancer Res., 54, 5296 Kamiya, 1995, Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion, 92, 1332 Hsieh, 1994, Dependence of transcriptional repression on CpG methylation density, Mot. Cell. Biol., 14, 5487, 10.1128/MCB.14.8.5487 Muiznieks, 1994, The impact of 5′-CG-3′ methylation on the activity of different eukaryotic promoters: a comparative study, FEBS Lett., 344, 251, 10.1016/0014-5793(94)00394-7 Antequera, 1993, Number of CpG islands and genes in human and mouse, 90, 11995 Cooper, 1990, The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions, Hum. Genet., 85, 55, 10.1007/BF00276326 Sved, 1990, The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model, 87, 4692 Bestor, 1994, DNA methyltransferases, Curr. Opin. Cell. Biol., 6, 380, 10.1016/0955-0674(94)90030-2 Jost, 1994, Transient DNA demethylation in differentiating mouse myoblasts correlates with higher activity of 5-methyldeoxycytidine excision repair, J. Biol. Chem., 269, 10040, 10.1016/S0021-9258(17)36987-9 Weiss, 1996, DNA demethylation in vitro: involvement of RNA., Cell, 86, 709, 10.1016/S0092-8674(00)80146-4 Baylin, 1991, Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression, Cancer Cells, 3, 383 Laird, 1994, DNA methylation and cancer, Hum. Mol. Genet., 3, 1487, 10.1093/hmg/3.suppl_1.1487 Balmain, 1995, Cancer. Exploring the bowels of DNA methylation, Curr. Biol., 5, 1013, 10.1016/S0960-9822(95)00204-1 Bird, 1996, The relationship of DNA methylation to cancer, Cancer Surveys Jones, 1996, DNA methylation errors and cancer, Cancer Res., 56, 2463 Laird, 1996, The role of DNA methylation in cancer genetics and epigenetics, Annu. Rev. Genet., 30, 441, 10.1146/annurev.genet.30.1.441 Counts, 1995, Alterations in DNA methylation may play a variety of roles in cardnogenesis, Cell, 83, 13, 10.1016/0092-8674(95)90228-7 Lapeyre, 1979, 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which result, Biochem. Biophys. Res. Commun., 87, 698, 10.1016/0006-291X(79)92015-1 Diala, 1983, Extent of DNA methylation in human tumor cells, J. Natl. Cancer. Inst., 71, 755 Gama-Sosa, 1983, The 5-methylcytosine content of DNA from human tumors, Nucleic Acids Res., 11, 6883, 10.1093/nar/11.19.6883 Feinberg, 1983, Hypomethylation distinguishes genes of some human cancers from their normal counterparts, Nature, 301, 89, 10.1038/301089a0 Baylin, 1986, DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas, Cancer Res., 46, 2917 Wu, 1993, Expression of an exogenous eukarvotic DNA methyltrans-ferase gene induces transformation of NIH 3T3 cells, 90, 8891 MacLeod, 1995, Expression of antisense to DNA methyl-transferase mRNA induces DNA demethylation and inhibits tumorigenesis, J. Biol. Chem., 270, 8037, 10.1074/jbc.270.14.8037 Laird, 1995, Suppression of intestinal neoplasia by DNA hypo-methylation, Cell, 81, 197, 10.1016/0092-8674(95)90329-1 Moser, 1990, A dominant mutation that pre-disposes to multiple intestinal neoplasia in the mouse, Science, 247, 322, 10.1126/science.2296722 Gonzalez-Zuleta, 1995, Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing, Cancer Res., 55, 4531 Herman, 1995, Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers, Cancer Res., 55, 4525 Merlo, 1995, 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor, Nat. Med., 1, 686, 10.1038/nm0795-686 Greenblatt, 1994, Mutations in the tumor suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855 Yang, 1996, The rate of CpG mutation in Alu repetitive elements within the 53tumor suppressor gene in the primate germline, J. Mol. Biol., 258, 240, 10.1006/jmbi.1996.0246 Shen, 1992, High frequency mutagenesis by a DNA methyltransferase, Cell, 71, 1073, 10.1016/S0092-8674(05)80057-1 Schmutte, 1996, Mechanisms for the involvement of DNA methylation in colon carcinogenesis, Cancer Res., 56, 2375 Jüttermann, 1994, Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation., 91, 11797 Jackson-Grusby, 1994, Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase Li, 1992, Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell, 69, 915, 10.1016/0092-8674(92)90611-F